Flputnam Investment Management CO Biogen Inc. Transaction History

Flputnam Investment Management CO

  • $4.61 Billion
  • Q1 2024

A detailed history of Flputnam Investment Management CO transactions in Biogen Inc. stock. As of the latest transaction made, Flputnam Investment Management CO holds 2,118 shares of BIIB stock, worth $483,052. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,118
Previous 1,931 9.68%
Holding current value
$483,052
Previous $499,000 8.62%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
BUY
$212.02 - $267.71 $39,647 - $50,061
187 Added 9.68%
2,118 $456,000
Q4 2023

Jan 30, 2024
SELL
$222.59 - $267.94 $41,179 - $49,568
-185 Reduced 8.74%
1,931 $499,000
Q3 2023

Nov 06, 2023
SELL
$253.3 - $285.89 $506 - $571
-2 Reduced 0.09%
2,116 $543,000
Q2 2023

Aug 14, 2023
BUY
$275.25 - $318.06 $14,313 - $16,539
52 Added 2.52%
2,118 $603,000
Q1 2023

Apr 27, 2023
BUY
$256.56 - $292.34 $14,880 - $16,955
58 Added 2.89%
2,066 $574,000
Q4 2022

Jan 31, 2023
SELL
$252.44 - $306.72 $18,175 - $22,083
-72 Reduced 3.46%
2,008 $556,000
Q2 2022

Aug 08, 2022
SELL
$187.54 - $223.02 $562 - $669
-3 Reduced 0.14%
2,080 $424,000
Q1 2022

Apr 28, 2022
SELL
$193.77 - $244.14 $11,238 - $14,160
-58 Reduced 2.71%
2,083 $439,000
Q2 2021

Aug 11, 2021
SELL
$259.0 - $414.71 $313,649 - $502,213
-1,211 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$242.95 - $284.63 $16,277 - $19,070
-67 Reduced 5.24%
1,211 $339,000
Q4 2020

Feb 02, 2021
SELL
$236.26 - $355.63 $271,699 - $408,974
-1,150 Reduced 47.36%
1,278 $313,000
Q3 2020

Nov 03, 2020
SELL
$264.77 - $305.71 $529 - $611
-2 Reduced 0.08%
2,428 $689,000
Q2 2020

Aug 13, 2020
SELL
$258.66 - $342.55 $288,664 - $382,285
-1,116 Reduced 31.47%
2,430 $650,000
Q1 2020

May 08, 2020
SELL
$268.85 - $341.04 $51,619 - $65,479
-192 Reduced 5.14%
3,546 $1.12 Million
Q3 2019

Nov 05, 2019
BUY
$217.44 - $243.88 $26,092 - $29,265
120 Added 3.32%
3,738 $870,000
Q1 2019

May 15, 2019
SELL
$216.71 - $338.96 $9,535 - $14,914
-44 Reduced 1.2%
3,618 $855,000
Q4 2018

Feb 22, 2019
BUY
$278.5 - $352.75 $696,250 - $881,875
2,500 Added 215.15%
3,662 $1.1 Million
Q2 2018

Aug 01, 2018
SELL
$257.52 - $306.91 $610,579 - $727,683
-2,371 Reduced 67.11%
1,162 $337,000
Q1 2018

May 01, 2018
SELL
$260.13 - $367.91 $4,682 - $6,622
-18 Reduced 0.51%
3,533 $967,000
Q4 2017

Feb 06, 2018
BUY
$307.64 - $344.58 $8,921 - $9,992
29 Added 0.82%
3,551 $1.13 Million
Q3 2017

Nov 07, 2017
BUY
$281.15 - $329.69 $990,210 - $1.16 Million
3,522
3,522 $1.1 Million

Others Institutions Holding BIIB

# of Institutions
1,047
Shares Held
126M
Call Options Held
1.37M
Put Options Held
1.35M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Flputnam Investment Management CO Portfolio

Follow Flputnam Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email